Form 4: Joseph C. Papa Acquires Stock Options in Candel Therapeutics, Inc.
SEC Form 4 Filing
Director Joseph C. Papa acquired stock options for 14,240 shares of Candel Therapeutics, Inc. on June 26, 2024.
Summary
- On June 26, 2024, Joseph C. Papa, a director of Candel Therapeutics, Inc., acquired stock options for 14,240 shares.
- The exercise price of the stock options is $5.71.
- The options vest on the earlier of June 26, 2025, or the date of the next Annual Meeting of Stockholders, contingent upon continued service on the Board of Directors.
- The options expire on June 26, 2034.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock option grants, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders, such as directors and officers, transact in their company's stock. This provides transparency to the market regarding insider activity.
Stakeholder Impact
- The acquisition of stock options by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 06/26/2024 | Date of transaction: Joseph C. Papa acquired stock options. |
| 06/26/2025 | Earliest vesting date for the stock options, contingent on continued service on the Board. |
| 06/26/2034 | Expiration date of the stock options. |
| 06/27/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.